P. Gaulard

P. Gaulard, F. Alsohaibani, Maheeba Abdulla, 2011, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion.

Pathology and biology of peripheral T‐cell lymphomas

P. Gaulard, L. de Leval, 2011, Histopathology.

Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization

C. Copie-Bergman, P. Gaulard, J. Bosq, 1998 .

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.

P. Gaulard, P. Dubreuil, O. Hermine, 2017, Oncotarget.

Cellular origin of T-cell lymphomas.

P. Gaulard, L. de Leval, 2014, Blood.

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

P. Gaulard, C. Gisselbrecht, N. Mounier, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.

C. Copie-Bergman, P. Gaulard, V. Meignin, 1998, The American journal of pathology.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

C. Copie-Bergman, T. Molina, F. Jardin, 2016, American journal of hematology.

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

P. Gaulard, R. Hustinx, O. Casasnovas, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

W. Chan, P. Gaulard, B. Dave, 2013, The American journal of pathology.

Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.

P. Gaulard, A. Rahmouni, É. Lepage, 2001, Radiology.

Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.

L. Staudt, A. Rosenwald, W. Chan, 2019, Blood.

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

R. Houot, P. Gaulard, H. Tilly, 2016, Oncotarget.

Pathologic and Clinical Features of 77 Hodgkin's Lymphoma Patients Treated in a Lymphoma Protocol (LNH87): A GELA Study

P. Gaulard, F. Berger, J. Diebold, 2001, The American journal of surgical pathology.

Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.

P. Gaulard, R. Bouabdallah, O. Casasnovas, 2021, Blood Advances.

Peripheral T‐cell lymphoma in HIV‐infected patients: a study of 17 cases in the combination antiretroviral therapy era

C. Copie-Bergman, P. Gaulard, É. Oksenhendler, 2013, British journal of haematology.

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

P. Gaulard, H. Tilly, L. de Leval, 2011, Blood.

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.

P. Gaulard, B. Petit, R. Gressin, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate

P. Gaulard, C. Haioun, M. Meignan, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma

C. Copie-Bergman, P. Gaulard, N. Brousse, 2003, Gut.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

P. Gaulard, B. Coiffier, H. Tilly, 2003, Blood.

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium

A. Rosenwald, Y. Natkunam, R. Advani, 2017, Haematologica.

Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.

P. Gaulard, M. Druet‐Cabanac, K. Leroy, 2001, Human pathology.

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality

P. Gaulard, F. Lemonnier, J. Ricci, 2022, Cancers.

The microenvironment in T-cell lymphomas: emerging themes.

P. Gaulard, L. de Leval, 2014, Seminars in cancer biology.

Molecular and Clinical Aspects of Angioimmunoblastic T-Cell Lymphoma

P. Gaulard, L. Leval, F. Foss, 2013 .

Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma

P. Gaulard, C. Gisselbrecht, L. de Leval, 2010, British journal of haematology.

Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples

P. Gaulard, G. Ott, S. Pileri, 2003, British journal of haematology.

Pathobiology of Primary Mediastinal B-Cell Lymphoma

P. Gaulard, F. Cavalli, S. Pileri, 2003, Leukemia & lymphoma.

Hepatosplenic αβ T-cell lymphoma : An unusual case with clinical, histologic, and cytogenetic features of γδ hepatosplenic T-cell lymphoma

P. Gaulard, G. Delsol, F. Suarez, 2000 .

CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC).

T. Molina, P. Gaulard, T. Petrella, 1999, The American journal of surgical pathology.

Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T‐cell lymphomas

P. Gaulard, O. Casiraghi, P. Kanavaros, 1997 .

Interleukin‐7 receptor expression in cutaneous T‐cell lymphomas

P. Gaulard, M. Bagot, J. Revuz, 1996, The British journal of dermatology.

Nasal T - c e l l Lymphoma: A Clinicopathologic Entity Associated With Peculiar Phenotype and With Epstein-Barr Virus

P. Gaulard, J. Bosq, F. Reyes, 2003 .

Lymphoma : A Clinicopathologic Entity Associated With Peculiar Phenotype and With Epstein-Barr Virus

P. Gaulard, J. Bosq, F. Reyes, 2003 .

EPSTEIN–BARR VIRUS IN NON‐HODGKIN'S LYMPHOMAS OF THE UPPER RESPIRATORY TRACT: ASSOCIATION WITH SINONASAL LOCALIZATION AND EXPRESSION OF NK AND/OR T‐CELL ANTIGENS BY TUMOUR CELLS

P. Gaulard, J. Brière, P. Kanavaros, 1996, The Journal of pathology.

Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV.

P. Gaulard, C. Meijer, J. Brière, 1995, Leukemia & lymphoma.

Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?

C. Copie-Bergman, P. Gaulard, K. Leroy, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy.

C. Copie-Bergman, P. Gaulard, K. Leroy, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome

C. Copie-Bergman, P. Gaulard, N. Brousse, 2001, American Journal of Gastroenterology.

Primary Hepatic Lymphoma of Mucosa-Associated Lymphoid Tissue Type: A Case Report With Cytogenetic Study

C. Copie-Bergman, P. Gaulard, J. Dierlamm, 2008, International journal of surgical pathology.

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.

P. Gaulard, B. Coiffier, H. Tilly, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

A. Rosenwald, R. Houot, M. Ziepert, 2022, HemaSphere.

Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients

P. Gaulard, F. Roudot-thoraval, D. Dhumeaux, 2002, Transplantation.

Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence.

P. Gaulard, D. Mason, M. Brown, 1992, Journal of clinical pathology.

Erythroblasts are a source of angiogenic factors.

P. Gaulard, P. Romeo, S. Ting, 2001, Blood.

MONOCLONAL ANTIBODY (HML-1) REACTIVITY OF T-CELL LYMPHOMAS

P. Gaulard, N. Brousse, A. Jarry, 1989, The Lancet.

Early lesions in lymphoid neoplasia

P. Gaulard, E. Jaffe, A. Wotherspoon, 2012, Journal of Hematopathology.

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations

P. Gaulard, L. de Leval, L. Quintanilla‐Martinez, 2016, Nature Communications.

Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes.

P. Gaulard, P. Marynen, A. Hagemeijer, 2000, Blood.

The EHA Research Roadmap: Malignant Lymphoid Diseases

B. Nadel, K. Tarte, M. Kersten, 2022, HemaSphere.

Nonhepatosplenic &ggr;&dgr; T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation

P. Gaulard, L. Colomo, E. Campo, 2011, The American journal of surgical pathology.

Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.

P. Gaulard, N. Martin, E. Zafrani, 1994, The American journal of pathology.

In situ detection of activated cytotoxic cells in follicular lymphomas.

P. Gaulard, N. Brousse, M. Peuchmaur, 1994, The American journal of pathology.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Y. Natkunam, W. Klapper, P. Gaulard, 2010, Haematologica.

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET 2 expression

Asnafi, Vahid, P. Gaulard, 2017 .

Recombination pattern of the TCR γ locus in human peripheral T‐cell lymphomas

P. Gaulard, M. Lefranc, M. Raphaël, 1994 .

Expression of the Alpha/Beta and Gamma/ Delta T-cell Receptors in 57 Cases of Peripheral T-cell Lymphomas Identification of a Subset of y/6 T-ceII Lymphomas

P. Gaulard, C. Haioun, J. P. Couédic, 2007 .

Preferential localisation of human lymphocytes bearing y5 T cell receptors to the red pulp of the spleen.

P. Gaulard, D. Mason, D. Bordessoule, 2022 .

Can peripheral T-cell lymphomas be morphologically subclassified? A morphometric approach to 21 cases.

P. Gaulard, F. Sigaux, G. Flandrin, 1986, Cytometry.

LYMPHOID NEOPLASIA CCND2 rearrangements are the most frequent genetic events in cyclin D1 (cid:1) mantle cell lymphoma

A. Rosenwald, W. Klapper, R. Siebert, 2013 .

Controversies in the Treatment of Peripheral T-cell Lymphoma

P. Gaulard, P. Zinzani, L. de Leval, 2020, HemaSphere.

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

P. Gaulard, F. Lemonnier, L. de Leval, 2022, Modern Pathology.

Detection of gene fusion transcripts in Peripheral T-cell Lymphoma using a multiplexed targeted sequencing assay.

F. Jardin, P. Gaulard, J. Picquenot, 2021, The Journal of molecular diagnostics : JMD.

New insights into breast implant-associated anaplastic large cell lymphoma

P. Gaulard, P. Brousset, C. Haioun, 2018, Current opinion in oncology.

Pathology of peripheral T-cell lymphomas: where do we stand?

P. Gaulard, L. de Leval, 2014, Seminars in hematology.

Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma

P. Gaulard, A. Stamatoullas, J. Picquenot, 2007, Leukemia.

Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.

P. Gaulard, L. Bélec, R. Gherardi, 1994, Blood.

High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.

P. Gaulard, B. Coiffier, H. Tilly, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

P. Gaulard, L. de Leval, P. Staber, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T-Cell/Histiocyt e-Rich L arge B -Cell L ymphomas a nd C lassical Diffuse L arge B -Cell L ymphomas H ave S imilar O utcome A fter Chemotherapy: A M atched-Control A nalysis

T. Molina, P. Gaulard, R. Bouabdallah, 2003 .

T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.

P. Gaulard, F. Triebel, C. Demeure, 2001, European journal of cancer.

Primary lymphoma of the liver: Clinical‐pathological features and relationship with HCV infection in French patients

P. Gaulard, P. Feugier, N. Brousse, 2003, Hepatology.

Hepatosplenic γδ T-cell Lymphoma is a Rare Clinicopathologic Entity with Poor Outcome : Report on a Series of 21 Cases . Short title : HEPATOSPLENIC γδ T-CELL LYMPHOMA

P. Gaulard, H. Tilly, E. Labouyrie, 2003 .

Polymerase chain reaction (PCR) amplification demonstrates the absence of human T-cell lymphotrophic virus (HTLV)-I specific pol sequences in peripheral T-cell lymphomas

P. Gaulard, C. Haioun, F. Reyes, 1990, Journal of Clinical Immunology.

Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed.

P. Gaulard, P. Chariot, I. Monnet, 1993, Human pathology.

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

F. Jardin, P. Gaulard, H. Tilly, 2018, Cancer medicine.

Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.

P. Gaulard, B. Coiffier, R. Bouabdallah, 2012, Clinical lymphoma, myeloma & leukemia.

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma.

P. Gaulard, B. Coiffier, C. Gisselbrecht, 2006, Haematologica.

FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

P. Gaulard, B. Coiffier, O. Casasnovas, 2004, Leukemia.

Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples.

P. Gaulard, N. Brousse, J. Emile, 1995, The American journal of surgical pathology.

Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas

W. Chan, P. Gaulard, A. Feldman, 2022, Virchows Archiv.

Follicular helper T cells: implications in neoplastic hematopathology.

P. Gaulard, L. de Leval, 2011, Seminars in diagnostic pathology.

F OLLICULAR HELPER T- CELLS : IMPLICATIONS IN NEOPLASTIC HAEMATOPATHOLOGY

P. Gaulard, L. Leval, 2011 .

Angioimmunoblastic T-cell lymphoma: a tumor of follicular helper T cells derivation with clinical and pathological relevance

P. Gaulard, L. Leval, C. Thielen, 2009 .

Pathobiology and Molecular Profiling of Peripheral T-cell Lymphomas

P. Gaulard, L. de Leval, 2022 .

Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T‐cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression

P. Gaulard, A. Hagemeijer, P. Pauwels, 2002, Genes, chromosomes & cancer.

Mediastinal Diffuse Large‐Cell Lymphoma with Sclerosis: A Condition with a Poor Prognosis

P. Gaulard, F. Roudot-thoraval, C. Haioun, 1989, American journal of clinical oncology.

RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells

P. Gaulard, S. Ogawa, F. Lemonnier, 2018, Haematologica.

Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups

C. Copie-Bergman, M. Calaminici, M. Baia, 2013, Histopathology.

The microenvironment in T-cell lymphomas

P. Gaulard, L. Leval, 2015 .

Peripheral T‐cell lymphoma presenting as predominant liver disease: A report of three cases

P. Gaulard, C. Haioun, E. Zafrani, 1986, Hepatology.

Anaplastic large cell lymphoma, ALK-positive and anaplastic large cell lymphoma ALK-negative

P. Gaulard, G. Delsol, L. Brugières, 2009 .

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients

P. Gaulard, R. Bouabdallah, H. Tilly, 2016, Haematologica.

Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

P. Gaulard, B. Coiffier, H. Tilly, 2010 .

Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases.

P. Gaulard, C. Haioun, M. Goossens, 1988, Blood.

MOLECULAR FEATURES OF HEPATOSPLENIC T-CELL POTENTIAL NOVEL THERAPEUTIC TARGETS

Elizabeth, P. Gaulard, F. Berger, 2012 .

Effective management of accelerated phase myelofibrosis with low‐dose splenic radiotherapy

P. Gaulard, E. Matutes, M. Bennett, 2010, American journal of hematology.

Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue.

P. Gaulard, J. Diebold, N. Martin, 1995, Journal of Clinical Pathology.

Interleukin-2 and interferon-gamma production in follicular lymphomas.

P. Gaulard, N. Brousse, M. Peuchmaur, 1991, American journal of clinical pathology.

VJ REARRANGEMENTS OF THE TCRγ LOCUS IN PERIPHERAL T‐CELL LYMPHOMAS: ANALYSIS BY POLYMERASE CHAIN REACTION AND DENATURING GRADIENT GEL ELECTROPHORESIS

P. Gaulard, M. Vidaud, M. Raphael, 1996, The Journal of pathology.

Expression of the bcl-2 gene product in follicular lymphoma.

P. Gaulard, J. Diebold, C. Gisselbrecht, 1992, The American journal of pathology.

Presence of HTLV‐I proviral DNA in patients with adult T‐Cell leukemia/lymphoma in Taiwan

P. Gaulard, T. Henni, C. Haioun, 1988 .

Bone Marrow Involvement in Lymphomas With Hemophagocytic Syndrome at Presentation: A Clinicopathologic Study of 11 Patients in a Western Institution

C. Copie-Bergman, P. Gaulard, Y. Allory, 2001, The American journal of surgical pathology.

Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas

C. Copie-Bergman, P. Gaulard, T. Marafioti, 2009, The American journal of surgical pathology.

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

P. Gaulard, A. Rahmouni, C. Haioun, 2005 .

Peripheral T / Nk Cell Lymphoma Clinic and Therapy

P. Gaulard, C. Gisselbrecht, 2004 .

94 T and NK Cell Lymphomas

P. Gaulard, 2004 .

Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft.

P. Gaulard, S. Swerdlow, A. Demetris, 2000, Transplantation.

Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center.

P. Gaulard, J. Pawlotsky, D. Dhumeaux, 1999, Blood.

The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee.

L. Staudt, W. Chan, W. Wilson, 2022, Blood.

Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site.

P. Gaulard, R. Willemze, J. Sabourin, 1994, Blood.

Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.

P. Gaulard, H. Adle-Biassette, J. Lelièvre, 2005, Journal of the American Academy of Dermatology.

Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study.

P. Gaulard, F. Roudot-thoraval, C. Haioun, 1992, Leukemia & lymphoma.

Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases.

P. Gaulard, C. Haioun, F. Reyes, 1991, Human pathology.

T‐Cell lymphoma revealed by a peripheral neuropathy: A report of two cases with an immunohistologic study on lymph node and nerve biopsies

P. Gaulard, R. Gherardi, J. Farcet, 1986, Cancer.

Expression of the alpha beta and gamma delta T-cell receptors in peripheral T-cell lymphomas.

P. Gaulard, C. Haioun, F. Reyes, 1990, Nouvelle revue francaise d'hematologie.

Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.

P. Gaulard, O. Casiraghi, P. Kanavaros, 1997, The Journal of pathology.

ALK is not expressed in Hodgkin disease.

P. Gaulard, F. Berger, E. Macintyre, 2001, Blood.

Clinicopathologic Characterization of Cyclin D1-Negative Mantle Cell Lymphoma

A. Rosenwald, R. Siebert, P. Gaulard, 2012 .

Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype

P. Gaulard, E. Jaffe, E. Berti, 2008 .

Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma

P. Gaulard, L. de Leval, P. Staber, 2020 .

Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment.

P. Gaulard, F. Reyes, M. Tulliez, 1988, Blood.

Epidermotropic secondary cutaneous involvement by relapsed angioimmunoblastic T‐cell lymphoma mimicking mycosis fungoides: a case report

P. Gaulard, L. Machet, N. Ortonne, 2012, Journal of cutaneous pathology.

Primary cutaneous follicular variant of peripheral T‐cell lymphoma NOS. A report of two cases

T. Molina, P. Gaulard, J. Diebold, 2010, Histopathology.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.

P. Gaulard, B. Coiffier, H. Tilly, 2001 .

Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma.

P. Gaulard, E. Macintyre, T. Marafioti, 2010, The American journal of pathology.

Short Communication Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma

P. Gaulard, E. Macintyre, T. Marafioti, 2010 .

Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement

C. Copie-Bergman, P. Gaulard, X. Mariette, 2005, Virchows Archiv.

ROQUIN/RC3H1 Alterations Are Not Found in Angioimmunoblastic T-Cell Lymphoma

K. Tarte, P. Gaulard, L. de Leval, 2013, PloS one.

Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia.

P. Gaulard, V. Meignin, A. Janin, 1998, Transplantation.

Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.

W. Chan, P. Gaulard, T. McKeithan, 2016, The American journal of pathology.

Hairy Cell Leukemia Associated With Large Granular Lymphocyte Leukemia: Immunologic and Genomic Study, Effect of Interferon Treatment

P. Gaulard, F. Reyes, M. Tulliez, 1988 .

Nasopharyngeal lymphomas: further evidence for a natural killer cell origin.

P. Gaulard, O. Casasnovas, T. Petrella, 1996, Human pathology.

Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder.

P. Gaulard, C. Haioun, F. Reyes, 1988, Cancer.

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

R. Siebert, P. Gaulard, R. De Wind, 2022, Haematologica.

Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation

P. Gaulard, L. Xerri, L. de Leval, 2022, Virchows Archiv.

Increased expression of interleukin-4 during liver allograft rejection.

P. Gaulard, E. Rouer, A. Louvel, 1999, Journal of hepatology.

Increased expression of interleukina during liver al&raft rejection

P. Gaulard, E. Zafrani, D. Houssin, 1999 .

Frequent Activating Mutations Of JAK-STAT Pathway Genes In Natural Killer Cell Lymphomas

C. Alkan, L. Staudt, W. Chan, 2013 .

Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation.

P. Gaulard, P. Ferrara, D. Caput, 1997, European cytokine network.

In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study

P. Gaulard, M. Hansmann, K. Willenbrock, 2004, Virchows Archiv.

LYMPHOID NEOPLASIA CD 10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells

K. Tarte, P. Gaulard, N. Martin, 2015 .

DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice

P. Gaulard, K. Helin, O. Bernard, 2016, Leukemia.

CD3‐T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar

P. Gaulard, F. Reyes, N. Oudrhiri, 1990, Clinical and experimental immunology.

A phase I study of IV aflibercept (Afl) in combination with R-CHOP in untreated patients (pts) with B-cell lymphoma.

F. Jardin, P. Gaulard, H. Tilly, 2010 .

Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up

I. Sobhani, C. Copie-Bergman, P. Gaulard, 2010, Leukemia & lymphoma.

Misleading Features of Bone Marrow Involvement by Peripheral T-Cell Lymphomas

P. Gaulard, S. Hoeller, 2012 .

Differences in Epstein-Barr Virus Expression Between Primary and Secondary Cutaneous Angiocentric Lymphomas

P. Gaulard, R. Willemze, R. Willemze, 1998 .

Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas.

P. Gaulard, M. Lefranc, C. Haioun, 1991, The Journal of clinical investigation.

dendritic cells that inhibits T-lymphocyte proliferation Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature

C. Copie-Bergman, M. Baia, P. Gaulard, 2013 .

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

A. Rosenwald, Y. Natkunam, M. Calaminici, 2022, Blood advances.

Progressive hemispheric atrophy in HIV: A Rasmussen's‐like variant of CD8 encephalitis?

P. Gaulard, M. Thom, H. Adle-Biassette, 2022, Neuropathology and applied neurobiology.

Early Response Evaluation with 18FDG-PET Scanning, but Not Phenotypic Profile, Are Predictive of Outcome in Diffuse Large B-Cell Lymphoma.

C. Copie-Bergman, P. Gaulard, A. Rahmouni, 2005 .

Characterization of CXCL13+ Neoplastic T Cells in Cutaneous Lesions of Angioimmunoblastic T-cell Lymphoma (AITL)

C. Copie-Bergman, P. Gaulard, C. Haioun, 2007, The American journal of surgical pathology.

Extranodal T- and NK-cell lymphomas

P. Gaulard, S. Pileri, A. Feldman, 2022, Virchows Archiv.

Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors:

D. Weisenburger, R. Warnke, C. Copie-Bergman, 2013 .

CD30+ lymphoproliferative disorders

P. Gaulard, L. de Leval, 2010, Haematologica.

Primary thrombocythaemia associated with systemic mastocytosis: a report of five cases

P. Gaulard, J. Diebold, C. Haioun, 1991, British journal of haematology.

Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection

P. Gaulard, Loëtitia Favre, O. Wagner-Ballon, 2022, Molecular Oncology.

Sjögren's syndrome and cutaneous B cell lymphoma revealed by anetoderma.

P. Gaulard, M. Bagot, A. Cosnes, 1993, Arthritis and rheumatism.

Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5‐Azacytidine

P. Gaulard, T. Petrella, K. Laribi, 2014, European journal of haematology.

Multifocal polyclonal Epstein–Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab

P. Gaulard, B. Bonaz, R. Gressin, 2010, Leukemia & lymphoma.

Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man.

P. Gaulard, C. Haioun, M. Delfau-Larue, 2009, Archives of pathology & laboratory medicine.

Epstein‐Barr Virus (EBV) Genomes and EBV‐Encoded Latent Membrane Protein (LMP) in Pulmonary Lymphomas Occurring in Nonimmunocompromised Patients

P. Gaulard, T. Petrella, J. Sabourin, 1993, American Journal of Surgical Pathology.

Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms.

Ash A. Alizadeh, Ryan D. Morin, B. Nadel, 2022, Blood.

lymphoproliferative disorders: a study of 87 cases Comparison of genetic probe with immunophenotype analysis in

P. Gaulard, C. Haioun, M. Goossens, 2011 .

Gammadelta T-cell lymphomas.

P. Gaulard, F. Reyes, K. Belhadj, 2003, Seminars in hematology (Print).

Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.

P. Gaulard, G. Delsol, F. Suarez, 2000, The American journal of surgical pathology.

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases.

P. Gaulard, M. Tulliez, A. Louvel, 2000, Journal of hepatology.

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

P. Gaulard, P. Brousset, L. Xerri, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

A. Rosenwald, R. Gascoyne, B. Sander, 2014, Haematologica.

Primary cutaneous peripheral T‐cell lymphomas with a T‐follicular helper phenotype: an integrative clinical, pathological and molecular case series study

P. Gaulard, Nadia Tazi, S. Dalle, 2022, The British journal of dermatology.

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

C. Copie-Bergman, P. Gaulard, S. Swerdlow, 2012, The American journal of surgical pathology.

Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3−/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic

P. Gaulard, Sonali M. Smith, E. Jaffe, 2016, Modern Pathology.

Nodal follicular helper T-cell lymphoma may present with different patterns. A case report.

T. Molina, P. Gaulard, J. Diebold, 2009, Human pathology.

Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

P. Gaulard, T. Mak, O. Bernard, 2017, Haematologica.

Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors

P. Gaulard, A. Vincent-Salomon, B. Asselain, 2009, American journal of hematology.

Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL): A New Diagnostic Marker Providing Evidence That AITL Derives From Follicular Helper T Cells

C. Copie-Bergman, P. Gaulard, C. Haioun, 2006, The American journal of surgical pathology.

[Acute mast cell leukemia disclosed by vasomotor flushing].

P. Gaulard, J. Roujeau, M. Tulliez, 1997, Annales de dermatologie et de venereologie.

A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23.

P. Gaulard, R. Favier, M. Portnoï, 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study

A. Rosenwald, N. Schmitz, P. Gaulard, 2010 .

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?

P. Gaulard, C. Cordonnier, D. Bories, 2011, European journal of haematology.

Peripheral neuropathy, coagulopathy and nodular regenerative hyperplasia of the liver in a patient with multiple serologic auto‐antibody activities and IgM B‐cell lymphoma

P. Gaulard, E. Zafrani, G. Defer, 1989, Journal of internal medicine.

Percutaneous Fine Needle Aspiration Cytology and Biopsy in the Diagnosis and Classification of Lymphoma: Clinical Evaluation.

P. Gaulard, C. Haioun, F. Reyes, 1991, Leukemia & lymphoma.

Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.

P. Gaulard, C. Haioun, F. Reyes, 1990, The American journal of pathology.

Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

P. Gaulard, C. Haioun, M. Goossens, 1990, Blood.

Lymphomatoid granulomatosis in a patient with acute myeloblastic leukemia in remission

P. Gaulard, X. Troussard, M. Leporrier, 1990, Cancer.

Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

Daniel‐Adriano Silva, W. Klapper, P. Gaulard, 2021, Nature Communications.

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis

J. D. Vos, K. Tarte, M. Baia, 2009, Leukemia.

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

R. Warnke, R. Gascoyne, P. Gaulard, 2002, Histopathology.

Nonepidermotropic cutaneous lymphomas. A histopathological and immunohistological study of 52 cases.

P. Gaulard, E. Zafrani, M. Bagot, 1994, Archives of pathology & laboratory medicine.

P. Gaulard, L. Bélec, R. Gherardi, 1994, Blood.

Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases

T. Molina, P. Gaulard, J. Diebold, 2008, Histopathology.

Eosinophilic Dysplasia of the Cervix: Which Are the Invasive and Cytologic Counterparts?

C. Copie-Bergman, P. Gaulard, Y. Allory, 2005 .

Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases

P. Gaulard, M. Bagot, J. Farcet, 1997, Journal of cutaneous pathology.

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

P. Gaulard, F. Berger, B. Coiffier, 1998, Blood.

des Lymphomes de l'Adulte (GELA) trials angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude Clinical, biologic, and pathologic features in 157 patients with

P. Gaulard, B. Coiffier, J. Diebold, 2013 .

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.

P. Gaulard, B. Coiffier, H. Tilly, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

P. Gaulard, B. Coiffier, J. Diebold, 2008, Blood.

Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression

P. Gaulard, P. Isaacson, M. Du, 2007, The American journal of surgical pathology.

Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.

P. Gaulard, F. Berger, B. Coiffier, 2006, Blood.

Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein–Barr virus infection. A different subtype of AILD-TL?

P. Gaulard, N. Brousse, D. Damotte, 2002, Leukemia.

Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas.

P. Gaulard, E. Campo, E. Montserrat, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymphomes non hodgkiniens. Aspects anatomocliniques

P. Gaulard, 1998 .

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.

P. Gaulard, F. Berger, J. Diebold, 1997, Blood.

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study

P. Gaulard, B. Coiffier, H. Tilly, 1996 .

Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.

P. Gaulard, J. Bosq, F. Reyes, 1993, Blood.

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.

P. Gaulard, J. Diebold, P. Biron, 1996, The American journal of surgical pathology.

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.

P. Gaulard, T. Petrella, C. Haioun, 1996, Blood.

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).

J Diebold, P. Gaulard, G. Salles, 1996, Blood.

Follicular variant of peripheral T cell lymphoma with mediastinal involvement in a child: a case report

P. Gaulard, P. Brousset, C. Laurent, 2015, Virchows Archiv.

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Christian Gisselbrecht, Karen Leroy, Françoise Berger, 2007, Blood.

lymphomas Prognostic significance of survivin expression in diffuse large B-cell

T. Molina, P. Gaulard, G. Salles, 2013 .

Primary lymphoma of the liver

P. Gaulard, E. Zafrani, 2008 .

Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease.

P. Gaulard, F. Authier, L. Bélec, 1999, Blood.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

P. Gaulard, S. Miyano, Y. Shiraishi, 2019, Leukemia.

Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.

P. Gaulard, C. Haioun, F. Reyes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HIV encephalitis‐like multinucleated giant cells in a nodal lymphoma in AIDS

P. Gaulard, F. Scaravilli, R. Gherardi, 1990, Histopathology.

Necrotizing vasculitis and HIV replication in peripheral nerves.

P. Gaulard, J. Bernaudin, F. Lebargy, 1989, The New England journal of medicine.

Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.

Lauren C. Chong, R. Gascoyne, P. Gaulard, 2018, Blood.

Associated Multicentric Castleman ' s Disease − Human Herpesvirus 8 Infection in Patients With POEMS Syndrome

P. Gaulard, F. Authier, L. Bélec, 1999 .

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2012, Blood.

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.

A. Rosenwald, R. Gascoyne, M. Calaminici, 2011, Blood.

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond

A. Rosenwald, P. Gaulard, E. Campo, 2016, Haematologica.

Functional plasticity and recurrent cell states of malignant B cells in follicular lymphoma

B. Nadel, P. Gaulard, F. Lemonnier, 2022, bioRxiv.

Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.

C. Copie-Bergman, P. Gaulard, M. Dyer, 2003, Blood.

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

P. Gaulard, F. Cavalli, S. Pileri, 2003, The American journal of pathology.

Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics

F. Jardin, P. Gaulard, A. Stamatoullas, 2002, Leukemia.

Interleukin 4 -induced gene 1 ( FIG1 ) is activated in primary mediastinal large B cell lymphoma Short running head : FIG1 gene activation in PMBL

P. Gaulard, P. Romeo, K. Leroy, 2002 .

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

W. Chan, P. Gaulard, P. Brousset, 2012, Blood.

T Cell Receptor Variable Region Gene Expression in Cutaneous T-Cell Lymphoma

P. Gaulard, M. Bagot, J. Revuz, 1994 .

De novo acute B cell leukemia/lymphoma with t(14;18)

P. Gaulard, A. Stamatoullas, S. Leprêtre, 2000, Leukemia.

Molecular classification of T-cell lymphomas.

P. Gaulard, L. de Leval, J. Boniver, 2009, Critical reviews in oncology/hematology.

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

Gwendoline Dubois, P. Gaulard, J. Jais, 2009, Blood.

The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations

P. Gaulard, F. Lemonnier, L. Quintanilla‐Martinez, 2019, Modern Pathology.

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

C. Copie-Bergman, P. Gaulard, C. Haioun, 2017, The American journal of surgical pathology.

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

P. Gaulard, S. Inoue, T. Mak, 2016, Proceedings of the National Academy of Sciences.

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

P. Gaulard, T. Mak, O. Bernard, 2012, Blood.

A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response

P. Gaulard, P. Romeo, O. Hermine, 2003, Nature Immunology.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

D. Dunson, I. Lossos, W. Chan, 2017, Cancer discovery.

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

W. Chan, D. Weisenburger, R. Warnke, 2013, Blood.

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.

P. Gaulard, F. Lemonnier, V. Imbert, 2019, Cancer cell.

with T FH -like features and adverse clinical parameters

P. Gaulard, J. Jais, T. Mak, 2016 .

-like features and adverse clinical parameters FH T mutations in peripheral T-cell lymphomas correlate with TET2 Recurrent

P. Gaulard, T. Mak, O. Bernard, 2013 .

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

P. Gaulard, F. Berger, B. Coiffier, 2003, Blood.

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

P. Gaulard, T. Marafioti, L. de Leval, 2010, Blood.

Low grade B cell mucosa associated lymphoid tissue lymphoma of the stomach: clinical and endoscopic features, treatment, and outcome.

P. Gaulard, C. Haioun, F. Reyes, 1992, Gut.

The mechanisms underlying MMR deficiency in immunodeficiency‐related non‐Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms

P. Gaulard, A. Duval, R. Hamelin, 2009, International journal of cancer.

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.

Ryan D. Morin, R. Gascoyne, P. Gaulard, 2016, Blood.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

R. Greil, P. Gaulard, G. Salles, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.

C. Copie-Bergman, M. Baia, T. Molina, 2015, Blood.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, G. Salles, B. Coiffier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

c‐Maf expression in angioimmunoblastic T‐cell lymphoma reflects follicular helper T‐cell derivation rather than oncogenesis

P. Gaulard, L. de Leval, J. Boniver, 2012, Histopathology.

Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology

W. Klapper, P. Gaulard, D. Jong, 2014, Histopathology.

Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell Lymphoma

P. Gaulard, K. Rajewsky, R. Küppers, 2001, The Journal of experimental medicine.

Peripheral T/NK‐cell lymphoma: a report of the IXth Workshop of the European Assocation for Haematopathology

P. Gaulard, H. Müller-Hermelink, S. Pileri, 2001, Histopathology.

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

P. Gaulard, F. Berger, C. Gisselbrecht, 2007, Blood.

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

K. Tarte, H. Kohrt, R. Houot, 2016, Oncoimmunology.

l'Adulte (GELA) non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de Prognostic significance of bcl-2 protein expression in aggressive

P. Gaulard, G. Salles, J. Diebold, 2002 .

Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma

P. Gaulard, G. Salles, J. Diebold, 1996 .

Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas

C. Copie-Bergman, P. Gaulard, P. Marynen, 2003, Leukemia.

The mutator pathway is a feature of immunodeficiency-related lymphomas.

P. Gaulard, F. Berger, G. Gaidano, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation

P. Gaulard, J. Pawlotsky, F. Roudot-thoraval, 1999, Hepatology.

Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

T. Molina, P. Gaulard, M. Tiemann, 2007, Leukemia.

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

F. Jardin, P. Gaulard, B. Coiffier, 2011, The Lancet. Oncology.

Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.

C. Copie-Bergman, M. Baia, T. Molina, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified

P. Gaulard, L. de Leval, S. Demeyer, 2021, Nature Communications.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

L. Staudt, A. Rosenwald, W. Chan, 2019, Blood.

Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma

P. Gaulard, K. Ohshima, M. Muratani, 2017, Leukemia.

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

P. Gaulard, M. Delorenzi, J. Jais, 2017, Haematologica.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets

T. Molina, P. Gaulard, F. Berger, 2015, Haematologica.

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

P. Gaulard, E. Solary, W. Vainchenker, 2014, Leukemia.

New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP

P. Gaulard, F. Lemonnier, J. Ricci, 2020, Oncogenesis.

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice.

Juan F. García, P. Gaulard, M. Piris, 2012, Blood.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Pierre Morel, Raoul Herbrecht, Felix Reyes, 2002, The New England journal of medicine.

Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

A Rosenwald, A. Rosenwald, R. Gascoyne, 2007, Journal of Clinical Pathology.

Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma

W. Chan, P. Gaulard, A. Bouska, 2015, Clinical Cancer Research.

IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.

P. Gaulard, A. Melnick, L. de Leval, 2023, Cancer cell.

Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

P. Gaulard, C. Haioun, F. Reyes, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

PATHOLOGY OF MUSCLE IN TRICHINOSIS: A SERIES OF 18 CASES

P. Gaulard, M. Baudrimont, R. Gherardi, 1989 .

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.

P. Gaulard, P. Brousset, C. Gisselbrecht, 2012, Blood.

A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients

P. Gaulard, J. Cayuela, É. Oksenhendler, 2021, The American journal of surgical pathology.

Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

P. Gaulard, L. de Leval, E. Missiaglia, 2021, The American journal of surgical pathology.

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

P. Gaulard, E. Jaffe, A. Feldman, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exclusive B‐cell phenotype of primary prostatic lymphomas: a potential role of chronic prostatitis

P. Gaulard, P. Brousset, L. Ysebaert, 2019, Histopathology.

T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome

T. Molina, P. Gaulard, H. Dombret, 2008, Clinical Cancer Research.

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

T. Molina, P. Gaulard, G. Salles, 2007, Leukemia.

Analysis of the intraclonal diversity of HLA‐A0201‐restricted T lymphocyte epitopes in follicular lymphoma idiotype

P. Gaulard, C. Haioun, J. Farcet, 2005, British journal of haematology.

Recombination pattern of the TCR gamma locus in human peripheral T-cell lymphomas.

P. Gaulard, M. Lefranc, M. Raphaël, 1994, The Journal of pathology.

TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

P. Gaulard, F. Berger, É. Lepage, 2004, Virchows Archiv.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

P. Gaulard, G. Salles, B. Coiffier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

P. Gaulard, H. Tilly, E. Labouyrie, 2003 .

Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

P. Gaulard, H. Tilly, E. Labouyrie, 2003, Blood.

T-Cell Lymphomas

P. Gaulard, F. Reyes, K. Belhadj, 2003 .

Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients

P. Gaulard, Y. Lévy, S. Katsahian, 2014, Mucosal Immunology.

Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets

P. Gaulard, M. Bagot, A. Bensussan, 2011, Journal of biomedicine & biotechnology.

Primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier

P. Gaulard, O. Chosidow, D. Boutboul, 2015, Journal of cutaneous pathology.

Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?

B. Nadel, K. Tarte, P. Gaulard, 2014, Blood.

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study

P. Gaulard, J. Jais, L. de Leval, 2022, Haematologica.

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P. Gaulard, F. d'Amore, L. Specht, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

New insights in the pathogenesis of T-cell lymphomas

P. Gaulard, F. Lemonnier, L. de Leval, 2018, Current Opinion in Oncology.

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations

P. Gaulard, M. Lipinski, L. Vassilev, 2015, Autophagy.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

L. Staudt, A. Rosenwald, W. Chan, 2006, Blood.

Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study

L. Staudt, A. Rosenwald, W. Chan, 2008 .

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Thomas Filleron, Jean-François Michiels, Peggy Dartigues, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD1d-restricted peripheral T cell lymphoma in mice and humans

P. Gaulard, G. Salles, J. Lachuer, 2016, The Journal of experimental medicine.

ALK+ subtypes reveals differences based on ALK status and two distinct morphologic Gene-expression profiling of systemic anaplastic large-cell lymphoma

P. Gaulard, D. Rickman, L. Lamant, 2013 .

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.

P. Gaulard, D. Rickman, G. Delsol, 2007, Blood.

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigentic reprogramming.

P. Gaulard, G. Salles, S. Mareschal, 2021, The Journal of clinical investigation.

Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice

P. Gaulard, S. Inoue, T. Mak, 2016, Proceedings of the National Academy of Sciences.

Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue.

P. Gaulard, F. Reyes, J. Plumas, 2001, International Immunology.

A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response

Olivier Hermine, P. Gaulard, P. Romeo, 2002, Nature Immunology.

[Leg ulcer associated with type I cryoglobulinaemia due to incipient B-cell lymphoma].

C. Copie-Bergman, P. Gaulard, C. Haioun, 2013, Annales de dermatologie et de venereologie.

Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment

P. Gaulard, Loëtitia Favre, J. Wiels, 2015 .

Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen.

P. Gaulard, D. Mason, D. Bordessoule, 1990, Journal of clinical pathology.

Molecular underpinning of extranodal NK/T-cell lymphoma.

P. Gaulard, L. de Leval, Yenlin Huang, 2013, Best practice & research. Clinical haematology.

CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Karin Tarte, K. Tarte, P. Gaulard, 2015, Blood.

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells

K. Tarte, P. Gaulard, T. Fest, 2012, Leukemia.

Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation.

Peter Möller, Karen Leroy, C. Copie-Bergman, 2007, Blood.

Epstein–Barr virus‐associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone

P. Gaulard, L. Michaux, Y. Guiot, 2002, European journal of haematology.

Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.

P. Gaulard, M. Vlychou, V. Gorgoulis, 1999, Anticancer Research.

Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology

F. Jardin, P. Gaulard, J. Picquenot, 2006, Oncogene.

Mechanisms of T‐cell Lymphomagenesis

P. Gaulard, F. Lemonnier, L. Leval, 2021 .

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

P. Gaulard, R. Bouabdallah, P. Brousset, 2019, Blood.

ALK-negative anaplastic large-cell lymphoma.

P. Gaulard, L. de Leval, 2016, Blood.

Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas

P. Gaulard, G. Salles, F. Berger, 2006, Oncogene.

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

P. Gaulard, G. Salles, A. Rahmouni, 2013, Haematologica.

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.

P. Gaulard, F. Lemonnier, C. Haioun, 2018, Blood.

Cytotoxic T-cell and NK-cell Lymphomas: Current Questions and Controversies

P. Gaulard, N. Harris, E. Jaffe, 2014, The American journal of surgical pathology.

Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization.

C. Copie-Bergman, P. Gaulard, J. Bosq, 1998, Blood.

Pyothorax-Associated Lymphoma: A Peculiar Clinicopathologic Entity Derived From B Cells at Late Stage of Differentiation and With Occasional Aberrant Dual B- and T-Cell Phenotype

C. Copie-Bergman, F. Jardin, P. Gaulard, 2002, The American journal of surgical pathology.

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

A. Rosenwald, R. Greil, M. Ziepert, 2020, Leukemia.

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

C. Copie-Bergman, M. Baia, T. Molina, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.

A. Rosenwald, N. Schmitz, P. Gaulard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation

F. Jardin, P. Gaulard, H. Tilly, 2021, Leukemia & lymphoma.

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.

Andrew Lister, Birgitta Sander, Edie Weller, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases.

P. Gaulard, R. Berger, C. Larsen, 1993, Leukemia.

CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

A. Rosenwald, W. Klapper, R. Siebert, 2013, Blood.

EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

F. Jardin, P. Gaulard, R. Bouabdallah, 2020, Blood.

Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma

P. Gaulard, E. Jaffe, M. Raffeld, 2005, The American journal of surgical pathology.

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

T. Molina, P. Gaulard, G. Salles, 2008, Leukemia.

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

C. Copie-Bergman, P. Gaulard, A. Rahmouni, 2007, Haematologica.

GENE EXPRESSION PROFILING OF SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA REVEALS DIFFERENCES DEPENDING ON ALK STATUS AND TWO DISTINCT MORPHOLOGICAL ALK SUBTYPES

P. Gaulard, A. Reyniès, G. Delsol, 2006 .

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Emmanuel Itti, Michel Meignan, Felix Reyes, 2005, Blood.

CD10 expression in diffuse large B-cell lymphomas does not influence survival

T. Molina, P. Gaulard, J. Diebold, 2004, Virchows Archiv.

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.

P. Gaulard, G. Salles, F. Berger, 2004, Blood.

Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus.

P. Gaulard, P. Brousset, M. Raphaël, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial

C. Copie-Bergman, T. Molina, F. Jardin, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

P. Gaulard, G. Salles, R. Bouabdallah, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

mantle cell lymphoma - D1 CCND2 rearrangements are the most frequent genetic events in cyclin

W. Klapper, R. Siebert, P. Gaulard, 2013 .

Acute megakaryocytic leukemia (AMKL) with major myelofibrosis in an infant. Diagnosis by liver biopsy and response to treatment.

P. Gaulard, J. Quillard, G. Tchernia, 1991, Nouvelle revue francaise d'hematologie.

Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study

P. Gaulard, F. d'Amore, L. de Leval, 2022, Blood.

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.

P. Gaulard, B. Quesnel, C. Gisselbrecht, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

ROQUIN / RC 3 H 1 alterations are not found in angioimmunoblastic T-cell lymphoma

K. Tarte, P. Gaulard, A. Reyniès, 2018 .

The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages

C. Copie-Bergman, M. Baia, P. Gaulard, 2009, Leukemia.

Primary extranodal CD8 positive epitheliotropic T‐cell lymphoma arising in a leiomyoma of the uterus

P. Gaulard, H. Merz, B. Koch, 2003, BJOG : an international journal of obstetrics and gynaecology.

T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.

T. Molina, P. Gaulard, R. Bouabdallah, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Classification des lymphomes non hodgkiniens

P. Gaulard, 2000 .

Peripheral neuropathy with distal nerve infiltration revealing a diffuse pleiomorphic malignant lymphoma

P. Gaulard, R. Gherardi, J. Poirier, 1987, Journal of Neurology.

Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging.

P. Gaulard, A. Rahmouni, É. Lepage, 2003, Radiology.

Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss.

P. Gaulard, D. Dhumeaux, C. Duvoux, 1993, Transplantation.

High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP.

L. Vercellino, P. Gaulard, G. Salles, 2020, Blood.

Tricky and terrible T-cell tumors: these are thrilling times for testing: molecular pathology of peripheral T-cell lymphomas.

P. Gaulard, L. de Leval, 2011, Hematology. American Society of Hematology. Education Program.

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model

P. Gaulard, J. Zucman‐Rossi, E. Solary, 2013, Haematologica.

Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey.

T. Molina, P. Gaulard, P. Brousset, 2022, Blood.

[Epithelial-myoepithelial carcinoma of the salivary glands. Study of 15 cases and review of the literature].

P. Gaulard, A. de Roquancourt, P. Fornés, 1991, Annales de pathologie.

Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay

C. Copie-Bergman, F. Jardin, P. Gaulard, 2019, Haematologica.

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

R. Greil, P. Gaulard, B. Coiffier, 2019, British journal of haematology.

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.

P. Gaulard, G. Salles, M. Copin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de Moelle.

P. Gaulard, N. Ifrah, H. Esperou, 1999, British journal of haematology.

Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.

P. Gaulard, C. Chastang, N. Brousse, 1987, The American journal of medicine.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma

C. Copie-Bergman, T. Molina, F. Jardin, 2020, Blood Cancer Journal.

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

F. Jardin, P. Gaulard, G. Salles, 2018, HemaSphere.

Rituximab in combination with CHOP regimen in angioimmunoblastic T-cell lymphoma: Results of the phase II RAIL trial--A prospective study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

P. Gaulard, O. Casasnovas, C. Gisselbrecht, 2010 .

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.

P. Gaulard, M. Delorenzi, L. de Leval, 2014, Blood.

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

C. Copie-Bergman, T. Molina, F. Jardin, 2011 .

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features

P. Gaulard, D. Rickman, T. Marafioti, 2013, Haematologica.

Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, J. Diebold, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activating mutations of STAT 5 B and STAT 3 in lymphomas derived from gdT or NK cells

C. Alkan, L. Staudt, W. Chan, 2015 .

Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial.

A. Rosenwald, M. Ziepert, N. Schmitz, 2017 .

Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia

P. Gaulard, J. Gris, J. Crouzet, 2018, Leukemia & lymphoma.

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

Karen Leroy, C. Copie-Bergman, P. Gaulard, 2004, Blood.

Recurrent mutations of the STAT 6 DNA binding domain in primary mediastinal B-cell lymphoma

Gwendoline Dubois, P. Gaulard, J. Jais, 2009 .

Constitutive STAT 6 activation in primary mediastinal large B-cell lymphoma

C. Copie-Bergman, P. Gaulard, K. Leroy, 2004 .

MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas

C. Copie-Bergman, P. Gaulard, P. Möller, 2002, Modern Pathology.

The MAL gene is expressed in primary mediastinal large B-cell lymphoma.

C. Copie-Bergman, P. Gaulard, P. Romeo, 1999, Blood.

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma

P. Gaulard, O. Casasnovas, L. de Leval, 2019, European journal of haematology.

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression

P. Gaulard, P. Dubreuil, O. Hermine, 2016, Oncotarget.

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.

P. Gaulard, R. Bouabdallah, D. Olive, 2020, Blood advances.

Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study

P. Gaulard, G. Salles, L. Fornecker, 2023, British journal of haematology.

Protein‐Losing Enteropathy in Gastrointestinal Sarcoidosis Associated with Malignant Lymphoma

P. Gaulard, B. Godeau, J. Farcet, 1992, Journal of clinical gastroenterology.

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma

P. Gaulard, V. Gouilleux-Gruart, K. Lassoued, 2009, Leukemia.

The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas

Y. Natkunam, R. Siebert, P. Gaulard, 2005, British journal of haematology.

MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte

C. Copie-Bergman, M. Baia, T. Molina, 2012 .

P. Gaulard, É. Oksenhendler, D. Droz, 2003, American journal of hematology.

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

A. Rosenwald, M. Ziepert, N. Schmitz, 2020, Blood.

MYC diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

or R-DHAP followed by BEAM plus autologous stem cell transplantation diffuse large B-cell lymphoma is not salvaged by classical R-ICE + MYC

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers.

P. Gaulard, R. Houlgatte, C. Gisselbrecht, 2017, Oncotarget.

Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK‐cell counts in rituximab–chemotherapy responsive elderly DLBCL patients: A LYSA group study

P. Gaulard, G. Salles, J. Jais, 2023, British journal of haematology.

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

Germinal Center Phenotype Determined by Immunohistochemistry on Tissue Microarray Does Not Correlate with Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy in the Randomized Trial LNH98-5. A GELA Study.

T. Molina, P. Gaulard, G. Salles, 2007 .

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma

Y. Natkunam, C. Copie-Bergman, R. Siebert, 2005, Leukemia.

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.

C. Copie-Bergman, P. Gaulard, F. Lemonnier, 2018, The Journal of molecular diagnostics : JMD.

Efficacy of 5‐Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma

P. Gaulard, F. Lemonnier, M. Cheminant, 2015, British journal of haematology.

Primary brain lymphoma cell turnover differs in patients with and without AIDS: relationships to bcl-2 expression and host cell reaction.

P. Gaulard, H. Adle-Biassette, C. Christov, 1999, Journal of neuropathology and experimental neurology.

Leucoencephalopathy with multinucleated giant cells containing human immune deficiency virus-like particles and multiple opportunistic cerebral infections in one patient with AIDS

P. Gaulard, M. Baudrimont, R. Gherardi, 2004, Acta Neuropathologica.

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.

P. Gaulard, H. Tilly, C. Haioun, 2017, European journal of cancer.

Hepatosplenic T-cell Lymphoma : Sinusal / Sinusoidal Localization of Malignant Cells Expressing the T-cell Receptor y 6

P. Gaulard, C. Haioun, F. Reyes, 2003 .

Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B‐cell lymphoma. A real‐world 112‐patient cohort

C. Copie-Bergman, P. Gaulard, C. Haioun, 2023, British journal of haematology.

Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma.

R. Houot, P. Gaulard, T. Fest, 2023, Leukemia.

Rituximab in combination with CHOP regimen in T-cell angioimmunoblastic lymphoma (AILD-TL) rich in large B cells. Favourable results in four patients.

P. Gaulard, A. Rahmouni, C. Haioun, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.

P. Gaulard, P. Dubreuil, A. Aouba, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatosplenic and other γδ T-cell lymphomas

P. Gaulard, L. Medeiros, F. Vega, 2007 .

Lack of reproducibility of histopathological features in MYC‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium

A. Rosenwald, Y. Natkunam, R. Advani, 2023, Histopathology.

Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis

T. Molina, P. Gaulard, J. Hamels, 2009, Leukemia and Lymphoma.

DNA methylation profiling of hepatosplenic T-cell lymphoma

A. Valencia, R. Siebert, P. Gaulard, 2018, Haematologica.

Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe

T. Molina, P. Gaulard, F. Berger, 2012 .

Mature T-cell lymphomas

P. Gaulard, L. Leval, 2015 .

The Gene Expression Profile of Nodal T-Cell Lymphomas Identifies a Molecular Link between Angioimmunoblastic T-Cell Lymphoma (AITL) and Follicular Helper T Cells (TFH), and between CD30+ Peripheral T-Cell Lymphoma and ALK-Negative Anaplastic Large Cell Lymphoma (ALCL).

T. Molina, P. Gaulard, F. Berger, 2006 .

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma

C. Copie-Bergman, T. Molina, F. Jardin, 2020, Blood Cancer Journal.

How molecular advances may improve the diagnosis and management of PTCL patients

P. Gaulard, F. Drieux, F. Lemonnier, 2023, Frontiers in Oncology.

[Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].

P. Gaulard, O. Bernard, C. Bastard, 2015, Medecine sciences : M/S.

Efficiency of In Vivo Purging With Rituximab Followed by High-Dose Therapy With Autologous Peripheral Blood Stem Cell Transplantation in B-Cell Non-Hodgkin’s Lymphomas: A Single-Institution Study

P. Gaulard, C. Haioun, F. Reyes, 2001 .

A phase II study of bortezomib in combination with intensified CHOP-like regimen (ACVBP) in patients with previously untreated T-cell lymphoma: Results of the GELA LNH05-1T trial.

P. Gaulard, B. Coiffier, F. Morschhauser, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY

P. Gaulard, J. Jais, F. Lemonnier, 2021, Hematological Oncology.

MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT

P. Gaulard, L. Xerri, M. Copin, 2021, Hematological Oncology.

ROCHOP study: A phase III randomized study of CHOP compared to romidepsin-CHOP in untreated peripheral T-cell lymphoma.

P. Gaulard, B. Coiffier, P. Zinzani, 2013 .

Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study

P. Gaulard, B. Coiffier, H. Tilly, 1993 .

Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas

P. Gaulard, F. Lemonnier, C. Haioun, 2016 .

Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion.

C. Copie-Bergman, M. Baia, P. Gaulard, 2009, Human pathology.

Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma.

P. Gaulard, E. Devilard, F. Bertucci, 2003, International Journal of Oncology.

Cutaneous pseudolymphomas: immunophenotypical and immunogenotypical studies.

P. Gaulard, M. Bagot, T. Henni, 1989, Current problems in dermatology.

Interleukin 7 receptor expression in cutaneous T-cell lymphomas

P. Gaulard, M. Bagot, J. Wechsler, 1994 .

Intraepidermal localization of the clone in cutaneous T-cell lymphoma.

P. Gaulard, M. Bagot, J. Revuz, 1992, Journal of the American Academy of Dermatology.

Carpal tunnel syndrome due to T cell lymphoma.

P. Gaulard, O. Hermine, F. Authier, 1995, Arthritis and rheumatism.

Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.

P. Gaulard, M. Tzardi, M. Kalmanti, 1992, Acta morphologica Hungarica.

Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.

C. Copie-Bergman, M. Baia, T. Molina, 2012 .

R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.

N. Schmitz, P. Gaulard, C. Gisselbrecht, 2007 .

Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay

Philippe Ruminy, David Gentien, Randy D Gascoyne, 2017, Haematologica.

Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression.

P. Gaulard, M. Hirst, M. Bilenky, 2020, Haematologica.

Sarcomatoid variant of anaplastic large cell lymphoma mimics ALK-1-positive inflammatory myofibroblastic tumor in bladder.

C. Copie-Bergman, P. Gaulard, Y. Allory, 2005, The American journal of surgical pathology.

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P. Gaulard, F. d'Amore, L. Specht, 2015 .

EPSTEIN–BARR VIRUS IN NON‐HODGKIN'S LYMPHOMAS OF THE UPPER RESPIRATORY TRACT: ASSOCIATION WITH SINONASAL LOCALIZATION AND EXPRESSION OF NK AND/OR T‐CELL ANTIGENS BY TUMOUR CELLS

P. Gaulard, J. Brière, P. Kanavaros, 1996, The Journal of pathology.

Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study

L. Staudt, A. Rosenwald, W. Chan, 2008 .

MYC diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

Peripheral T-Cell Lymphoma, Not Otherwise Specified

P. Gaulard, F. Drieux, 2019, Encyclopedia of Pathology.

Recurrent Mutations of the Exportin 1 Gene (XPO1) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

C. Copie-Bergman, T. Molina, F. Jardin, 2015 .

Successful allogeneic hematopoietic stem cell transplantation in a child with angioimmunoblastic T‐cell lymphoma: A case report

P. Gaulard, G. Damaj, V. Minard, 2023, Pediatric blood & cancer.

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

P. Gaulard, L. Specht, L. Trümper, 2015 .

Primary mediastinal B‐cell lymphoma

P. Gaulard, F. Cavalli, S. Pileri, 2007, Hematological oncology.

Primary intestinal gamma‐delta T‐cell lymphoma with evidence of Epstein–Barr virus

C. Copie-Bergman, P. Gaulard, R. Houdart, 1998, Histopathology.

Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.

P. Gaulard, N. Martin, F. Charlotte, 1995, The American journal of pathology.

Clinical Trials and Observations

L. Staudt, A. Rosenwald, W. Chan, 2007 .

Peripheral T cell lymphoma with Sjögren's syndrome: a report with immunologic and genotypic studies.

P. Gaulard, J. Farcet, M. Voisin, 1991, The Journal of rheumatology.

Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study

L. Staudt, A. Rosenwald, W. Chan, 2008 .

severe combined immunodeficiency caused by complete deficiency of the CD 3 subunit of the T-cell antigen receptor complex

L. Staudt, A. Rosenwald, W. Chan, 2007 .

Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients.

L. Staudt, A. Rosenwald, T. Greiner, 2012, Blood.

MYC diffuse large B-cell lymphoma is not salvaged by classical RICE or R-DHAP followed by BEAM plus autologous stem cell transplantation

A. Rosenwald, P. Gaulard, R. Houlgatte, 2012 .

Influence of translocation t(11;18) on response to conservative treatment of MALT gastric lymphoma (MGL)

C. Copie-Bergman, P. Gaulard, K. Leroy, 2003 .

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .

Hepatosplenic and other gammadelta T-cell lymphomas.

P. Gaulard, L. Medeiros, F. Vega, 2007, American Journal of Clinical Pathology.

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations

P. Gaulard, M. Lipinski, L. Vassilev, 2015, Autophagy.

Molecular underpinning of extranodal NK/T-cell lymphoma.

P. Gaulard, L. de Leval, Yenlin Huang, 2013, Best practice & research. Clinical haematology.

Follicular Peripheral T-cell Lymphoma Expands the Spectrum of Classical Hodgkin Lymphoma Mimics

C. Copie-Bergman, P. Gaulard, S. Swerdlow, 2012, The American journal of surgical pathology.

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: fin

L. Staudt, D. Weisenburger, J. Vose, 2008 .

ALK-negative anaplastic large-cell lymphoma.

P. Gaulard, L. de Leval, 2016, Blood.

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

P. Gaulard, T. Cluzeau, E. Durot, 2022, Blood advances.

Bilateral tumoral infiltration of the Achilles tendons revealing chronic myelomonocytic leukemia.

P. Gaulard, A. Rahmouni, O. Hermine, 1993, Arthritis and rheumatism.

Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas

C. Copie-Bergman, P. Gaulard, T. Marafioti, 2009, The American journal of surgical pathology.

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

P. Gaulard, H. Tilly, L. de Leval, 2011, Blood.

Clinical , biologic , and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d ’ Etude des Lymphomes de l ’ Adulte ( GELA ) trials

P. Gaulard, B. Coiffier, R. Bouabdallah, 2008 .

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

F. Jardin, P. Gaulard, H. Tilly, 2023, Blood advances.

Primary breast non‐Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors

P. Gaulard, A. Vincent-Salomon, B. Asselain, 2009, American journal of hematology.

large B-cell lymphoma of Waldeyer ’ s ring has distinct clinicopathologic features: a GELA study

C. Copie-Bergman, M. Baia, P. Gaulard, 2012 .

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

P. Gaulard, T. Marafioti, L. de Leval, 2010, Blood.

c‐Maf expression in angioimmunoblastic T‐cell lymphoma reflects follicular helper T‐cell derivation rather than oncogenesis

P. Gaulard, L. de Leval, J. Boniver, 2012, Histopathology.

Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?

P. Gaulard, M. Delfau-Larue, B. Bisig, 2023, Histopathology.

Pathology and biology of peripheral T‐cell lymphomas

P. Gaulard, L. de Leval, 2011, Histopathology.

T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome

T. Molina, P. Gaulard, H. Dombret, 2008, Clinical Cancer Research.

Peripheral T-Cell Lymphoma, Not Otherwise Specified

P. Gaulard, F. Drieux, 2019, Encyclopedia of Pathology.

Hepatosplenic T-Cell Lymphoma

P. Gaulard, F. Lemonnier, 2019, Encyclopedia of Pathology.

Pathobiology and molecular profiling of peripheral T-cell lymphomas.

P. Gaulard, L. de Leval, 2008, Hematology. American Society of Hematology. Education Program.

Angioimmunoblastic T-Cell Lymphoma: A Clinicopathologic Study of 158 Patients Treated in GELA (Groupe d’ Etude des Lymphomes de l’ Adulte) Trials.

T. Molina, P. Gaulard, J. Diebold, 2006 .

Other peripheral T cell lymphomas: pathology and molecular pathogenesis

P. Gaulard, J. Dupuis, 2010 .

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

A. Rosenwald, Y. Natkunam, R. Advani, 2023, HemaSphere.